Skip to content
Open access · CC-BY via OpenAlex

NAD+ depletion drives age-related monocyte hyperinflammation after stroke and is reversed by nicotinamide riboside

Mica Cabrera, Brent Eastman, Hannah E. Ennerfelt, Abrar I. Alsaadi, L. А. Alexandrova, Yeonglong Albert Ay, Jolie Huang, Qian Wang, Eran Blacher, Melanie R. McReynolds, Katrin I. Andreasson, Chinyere Agbaegbu Iweka

Journal of Neuroinflammation · 2025 · ▲ 3 citations

Abstract

BACKGROUND: Aging exacerbates post-stroke inflammation, contributing to worse neurological outcomes. However, the mechanisms underlying this age-dependent immune dysregulation remain unclear. Because immune cell metabolism critically shapes inflammatory responses, we investigated whether the metabolic state of circulating monocytes, key immune cells that traffic to the ischemic brain, is altered by age after stroke. We further examined whether enhancing cellular NAD+ availability with nicotinamide riboside (NR) could mitigate age-associated neuroinflammatory responses and improve stroke outcome. METHODS: Ischemic stroke was induced in young and aged mice using the distal middle cerebral artery occlusion model. We assessed monocyte metabolic profiles via untargeted metabolomics, mitochondrial function assays, multi-analyte cytokine/chemokine profiling, and flow cytometry. Given the contribution of monocyte-derived intestinal macrophages to gut barrier disruption after stroke, we evaluated gut barrier integrity, immune cell composition, and systemic inflammation. Stroke outcomes were also determined by infarct size, motor function, and brain inflammatory status. RESULTS: Our findings show that the availability of the essential energy co-factor, NAD+, is a key age-dependent factor that regulates monocyte and intestinal macrophage immune responses after stroke. Aged monocytes showed decreased NAD+ levels and increased inflammatory responses compared to young monocytes. Pretreatment with NR elevated cellular NAD+ levels in aged monocytes, normalized intestinal macrophage numbers and activation states, preserved gut barrier integrity, reduced systemic and brain inflammation, and improved stroke outcomes in aged mice. CONCLUSION: These findings highlight the importance of NAD+ in mitigating the post-stroke response in aging and the potential of NAD+ supplementation as a preventive strategy for patients at risk for cerebrovascular disease.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1186/s12974-025-03638-6
Canonical
link ↗
Fetched
2026-11-12 MST

Cite this

APA
Cabrera, M., Eastman, B., Ennerfelt, H.E., Alsaadi, A.I., Alexandrova, L.�., Ay, Y.A., Huang, J., Wang, Q., Blacher, E., McReynolds, M.R., Andreasson, K.I., &amp; Iweka, C.A. (2025). NAD+ depletion drives age-related monocyte hyperinflammation after stroke and is reversed by nicotinamide riboside. <em>Journal of Neuroinflammation</em>. https://doi.org/10.1186/s12974-025-03638-6
Vancouver
Cabrera M, Eastman B, Ennerfelt HE, Alsaadi AI, Alexandrova L�, Ay YA, et al. NAD+ depletion drives age-related monocyte hyperinflammation after stroke and is reversed by nicotinamide riboside. Journal of Neuroinflammation. 2025. doi:10.1186/s12974-025-03638-6.
BibTeX
@article{mica2025NADdep, title = {NAD+ depletion drives age-related monocyte hyperinflammation after stroke and is reversed by nicotinamide riboside}, author = {Mica Cabrera and Brent Eastman and Hannah E. Ennerfelt and Abrar I. Alsaadi and L. А. Alexandrova and Yeonglong Albert Ay and Jolie Huang and Qian Wang and Eran Blacher and Melanie R. McReynolds and Katrin I. Andreasson and Chinyere Agbaegbu Iweka}, journal = {Journal of Neuroinflammation}, year = {2025}, doi = {10.1186/s12974-025-03638-6}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings